FMP
EURONEXT
0.14 EUR
0 (0%)
Mr. Cathal Martin Friel
Healthcare
Biotechnology
https://www.openorphan.com
EURONEXT
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (...
N/A
N/A
N/A
21 Plumbers Row
44 20 7756 1300
GB
218
Jan 18, 2016
-
EURONEXT
Biotechnology
Healthcare
-
-
GB
0.14
0.75
192
0
-
0.14-0.14
0
-
-
-
-
0
-
https://www.openorphan.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.